China Life Insurance to Renew Investment Management Agreement with CLI
China Life Insurance Co (HK:2628) announced plans to renew its investment management agreement with subsidiary CLI, effective January 2026. This agreement, categorized as continuing connected transactions, requires independent shareholder approval due to significant percentage ratios. An extraordinary general meeting will be held for this purpose. The agreement aims to enhance investment management services and ensure regulatory compliance. The latest analyst rating for HK:2628 is a Buy with a price target of HK$31.00. China Life Insurance is a key player in the insurance sector, focusing on alternative investments.
China Life Insurance Co ( (HK:2628) ) has shared an announcement.
China Life Insurance Company Limited has announced plans to enter a new agreement with its subsidiary, CLI, for the management of insurance fund investments. This agreement, effective from January 2026, will see CLI continue to manage assets on behalf of China Life, with the transactions categorized as continuing connected transactions under Hong Kong’s listing rules. The agreement requires independent shareholder approval due to the significant percentage ratios involved, and an extraordinary general meeting will be convened for this purpose. The new agreement aims to ensure compliance with regulatory requirements and enhance investment management services, potentially impacting the company’s operational efficiency and stakeholder interests.
The most recent analyst rating on (HK:2628) stock is a Buy with a HK$31.00 price target. To see the full list of analyst forecasts on China Life Insurance Co stock, see the HK:2628 Stock Forecast page.
More about China Life Insurance Co
China Life Insurance Company Limited is a major player in the insurance industry, providing a range of insurance products and services. The company focuses on leveraging insurance funds for alternative investments, which are managed by its connected entities.
Average Trading Volume: 74,677,873
Technical Sentiment Signal: Buy
Current Market Cap: HK$1170.9B
